Articles in the ‘Risperdal Lawsuit’ Category

Nipples Enlargement Due to Risperdal

Risperdal is an atypical antipsychotic medication manufactured and marketed by Janssen Pharmaceuticals, under the parent company Johnson & Johnson. Primarily, Risperdal (generic name: risperidone) is prescribed to patients who suffer from schizophrenia, bipolar disorder, and irritability in children and adolescents with autistic disorder. However, it has been prescribed to a large number of patients for other “off-label” uses including dementia, attention deficit disorder, and even anxiety. Furthermore, Risperdal has been prescribed to hundreds of thousands of children, many of whom were given the medication prior to its FDA approval for use in children. Risperdal comes with many potential side effects and adverse events, but some of the most troubling, including nipple enlargement and lactation, are the result of hyperprolactinemia.

Risperdal Hyperprolactinemia Side Effects

Hyperprolactinemia occurs when a patient maintains an elevated blood level of the hormone “prolactin.” This happens in patients who take Risperdal because the drug acts as a “dopamine antagonist” and targets the dopamine receptor responsible for prolactin regulation in the body. The results of Risperdal hyperprolactinemia can be very troubling, especially when the breasts and nipples of males and male children undergo enlargement.

Gynecomastia: This disorder is when a male experiences a swelling or growth of breast tissue on one or both sides. It can be physically painful as well as a source of embarrassment. Nipples may be come enlarged and even have discharge as well. Presently, gynecomastia is considered irreversible, and the only effective treatment is surgical removal. Risperdal gynecomastia victims have reported breasts as large as a 38D.

Galactorrhea: This condition is another Risperdal hyperprolactinemia side effect that can produce the enlargement of nipples in both males and females. As its name suggests, galactorrhea is the spontaneous flow of milk from the breasts, but in this disorder it is unrelated to pregnancy or breast feeding. Male Risperdal patients as young as 4 years old have lactated. Alarmingly, four year olds are not in the FDA approved age range for Risperdal treatment.

File a Risperdal Nipple Enlargement Lawsuit

If you have experienced gynecomastia, galactorrhea, or nipples enlargement after taking the Johnson & Johnson antipsychotic Risperdal, you may want speak with a lawyer. A qualified Risperdal attorney can help evaluate the details of your case and assess whether a lawsuit is the best choice for you and your family. Contact the Willis Law firm today if you or a loved one has experienced serious Risperdal side effects. You may be legally entitled to financial compensation.

Risperdal Lawsuit Evaluation – Call Nationwide 1-800-883-9858

 

A prescription atypical antipsychotic, Risperdal, has been linked to a high risk of male breast development by growing body of medical research studies as well as lawsuits filed against its manufacturer, Johnson & Johnson.

The drug is approved by the US Food & Drug Administration for the following indications and usage:
• Treatment of schizophrenia in adults and adolescents aged 13-17 years
• Alone, or in combination with lithium or valproate, for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder in adults, and alone in children and adolescents aged 10-17 years
• Treatment of irritability associated with autistic disorder in children and adolescents aged 5-16 years.

While “changes in body weight” is an adverse effect mentioned in the FDA approved prescribing information for Risperdal, there is no mention of male breast development. The occurrence of Risperdal related gynecomastia cannot simply be attributed to weight gain; a number of male adolescents and children taking the drug have even begun to lactate. Breasts as large as 38D have been observed on young men, and in at least one case a double mastectomy was required for the treatment.

These horrifying scenarios are not simply due to the “changed in body weight” included in prescribing information.  Something else is going on to produce this male breast development, sometimes referred to as man boob syndrome. Many of these Risperdal victims choose to file a lawsuit against Johnson & Johnson for the financial, physical, and emotional distress resulting from this drug.

Risperdal FDA Black Box Warning

In 2006, the FDA included a Black Box Warning regarding atypical antipsychotics, including Risperdal, and an increased risk of death in patients with dementia-related psychosis. Interestingly, risperidone has not even been approved by the agency for this indication. Dementia, anxiety, and anger management are several of the unapproved uses for Risperdal that Johnson & Johnson has been accused of illegally advertising. In August of 2012, J&J paid around $180 million to settle accusations from over 30 states that it had promoted Risperdal and another drug, Invega, for unapproved indications. The first Risperdal lawsuit claim filed regarding male breast development (known by some as “man boob syndrome”) was settled in 2012.

Risperdal Side Effects

Gynecomastia (medical term for the development of enlarged breasts in males) can exhibit the following symptoms: swollen breasts, tenderness in breast tissue, swelling, discharge from breasts (signs of lactation), and pain. While it sometimes resolves itself, male breast growth may require surgical treatment in some cases for one or both breasts. Most devastating are the emotional ramifications of Risperdal gynecomastia. The growth of female breasts and experience of lactation frequently result in significant emotional trauma when experience by males, especially adolescent males and male children.

Other Serious Risperdal side effects include:
• Tardive dyskinesia
• Hyperprolactinemia
• Cerebrovascular events in elderly patients
• Neuroleptic Malignant Syndrome
• Hyperglycemia and diabetes mellitus
• Leukopenia, Neutropenia, and Agranulocytosis
• Orthostatic hypotension
• Seizures
• Potential for cognitive and motor impairment
• Priapism
• Dysphagia
• Suicide
• Disruption of body temperature regulation
• Increased sensitivity in patients with Parkinson’s disease or dementia with Lewy bodies
• Antiemetic Effect

Commonly reported adverse effects from Risperdal include:
• Somnolence
• Fatigue
• Increased Appetite
• Rhinitis
• Vomiting
• Coughing
• Abdominal pain
• Anxiety
• Dizziness
• Agitation
• Akathisia
• Upper Respiratory Tract Infections
• Rashes
• Dry Mouth
• Tremors
• Dyspepsia
• Increased saliva production
• Urinary incontinence
• Constipation
• Fever• Parkinsonism

Experiencing Male Breast Development? File a Risperdal Lawsuit

As listed above, the drug Risperdal includes a troubling list of adverse health effects, including the development of breasts in males. If your or a loved one is the victim of Risperdal gynecomastia, please contact the product liability lawyers at the Willis Law Firm today. We are available to evaluate your potential Risperdal lawsuit free of charge or further obligation; in fact, you will not be responsible for any attorney or legal fees unless a recovery is obtained in your favor. Don’t delay; let us help you stand up against this harmful drug today.

Free Risperdal Lawsuit Evaluation – Call Nationwide 1-800-883-9858

Male breast growth, known in the medical community as Gynecomastia, is a troubling side effect of the Johnson & Johnson prescription antipsychotic drug Risperdal (generic name risperidone). Although the drug was approved several years earlier for use in adults, it was not FDA approved for use in children until 2007. Since that approval, an alarming number of young males (some as young as four years old!) have begun to develop breast tissue. Some of these boys and young men have even begun lactating.

This Risperdal male breast growth can likely be attributed to the drug’s property of raising levels of the hormone prolactin in the body. As its name suggests, this hormone is responsible for breast growth and lactation; it secreted by the pituitary gland. Treatment with the antipsychotic Risperdal results in a very high level of prolactin in the body. Risperidone is the only atypical antipsychotic with this hyperprolactinaemia effect; the reason for this side effect is that the drug antagonizes the dopamine receptors that usually inhibit prolactin production. Regardless of the biological mechanisms by which Risperdal male breast growth occurs, this drug is causing young males receiving psychiatric treatment to grow breasts, some as large as a 38D.

Long Term Effects of Risperdal Male Breast Growth

Although the gynecomastia (male breast growth) resulting from Risperdal treatment does not usually present serious health problems, the emotional and psychological effects can be absolutely devastating. This medication, prescribed to help treat psychiatric and emotional disorders is simultaneously causing grave emotional damages. Sometimes gynecomastia goes away by itself, but other cases require surgery or additional medications for treatment. Risperdal male breast growth victims may need to undergo a single or double mastectomy, a surgery typically used in the treatment or prevention of breast cancer.

Risperdal and Male Breast Growth Lawsuit News

The link between J&J’s Risperdal and male breast growth has been covered by several large media outlets. Bloomberg reported about a young adult man whose Risperdal gynecomastia lawsuit was settled on the first day of trial proceedings. The amount of the settlement was not disclosed, but the man’s attorney reported that his client was satisfied with the outcome. This man was prescribed Risperdal as a child from the years of 2000-2004, years before it was FDA approved for the treatment of children.
In September 2012, Forbes magazine published an article titled “J&J Sees Male Breasts And Quickly Settles Risperdal Suit.” This article detailed the settlement of one Risperdal victim who had to have surgery for the removal of the breasts he grew after taking Risperdal as a child. Risperdal did not carry any warning regarding the male development of breasts; alarmingly this side effect has a much higher risk for children who take the drug. Forbes also detailed how J&J had to pay hundreds of millions of dollars regarding claims that the company actively promoted Risperdal for a number of unapproved uses.

File a Risperdal Lawsuit: Speak to a Risperdal Male Breast Growth Attorney

If you or a loved one has experienced male breast growth as the result of taking Risperdal (risperidone), contact the product liability team at the Willis Law Firm. We are currently reviewing gynecomastia lawsuit cases nationwide, and can help you and your family get the settlement you deserve. There may be a statue of limitation that limits the time you have available to file your claim, so do not delay! Join the hundreds of people exercising their rights and holding Johnson & Johnson responsible for their defective and harmful product.

Free Risperdal Lawsuit Evaluation – Call Nationwide 1-800-883-9858

Last fall, Johnson & Johnson settled with 6 of the males suing the company due to their affliction with gynecomastia following use of the prescription drug Risperdal. Although the amount of compensation received in these settlements is confidential, an attorney reported to several media outlets that plaintiffs were satisfied with what they received. Thousands of additional Risperdal Gynecomastia Lawsuit claims have been filed as the number of men, teenaged males, and boys as young as four are diagnosed with this unwarned side effect of breast growth. Bloomberg News reported that as of September 2012, there were around 130 lawsuits filed against J&J relating to Risperdal and Gynecomastia. In the time since then, the number has gone into the thousands.

What is Risperdal?

Risperdal (generic name risperidone) is a psychiatric medication known as an atypical antipsychotic drug.  Usually, this product is prescribed in the treatment of schizophrenia, adolescent schizophrenia, bipolar disorder, schizoaffective disorder, as well as irritability and aggression in autistic patients.

Although it was approved for the treatment of schizophrenic adults in 1993, Risperdal was not approved for use in children until 2007. Following this FDA approval, its use in children has increased rapidly. Johnson & Johnson, the company that manufactures and markets Risperdal, has been accused of promoting risperidone (Risperdal) for unapproved uses including dementia, anxiety disorders, and even anger management. Patients taking Risperdal for the unapproved use of dementia were determined to have an increased rate of mortality as determined by the US Food and Drug Administration.

What is Gynecomastia?

Gynecomastia is the medical term given to the swelling and growth of breast tissue in males, and this condition can affect either one or both of the breasts. Despite the lack of serious health threats, gynecomastia often results in significant emotional and psychological injuries to those it afflicts. Not only do males experience breast growth, sometimes they will also experience painful swelling and/or discharge from one or both breasts.

In some cases, gynecomastia is the result of changes in hormones during different physical development stages (infancy, puberty, between ages 50-80) due to changes in hormones. However, many prescription medications, including Risperdal, can cause this embarrassing and emotionally damaging condition.

Does Risperdal Cause Gynecomastia in Young Males?

As early as 1999, the Psychopharmacology Journal published a study implicating Risperdal in the development of male breasts when used with the antidepressant fluoxetine (Prozac). In June of 2006, Risperdal alone was linked to gynecomastia in young males by a study at Duke University. In this research scientists discovered both an increased risk of gynecomastia in males taking Risperdal and that many females taking the drug began to lactate before even reaching puberty. This link between males developing enlarged breasts and taking a risperidone antipsychotic medication is believed to be due to the drug’s property of increasing levels of prolactin, a hormone that regulates both breast growth and lactation.

File a Risperdal Lawsuit: Speak to a Gynecomastia Lawyer Today

If you or a loved one is experiencing the growth of breast tissue in males following use of the prescription antipsychotic medicine Risperdal, call the Willis Law Firm today, so we can properly evaluate your claim. This condition should not have happened to you, and the attorneys at our nationally recognized firm want to help you and your family obtain the settlement you deserve.

Located in Houston, TX, the Willis Law Firm and Team are currently pursuing over 500 cases of Risperdal Gynecomastia nationwide. Contact us as soon as possible because the window of time to pursue legal action is limited.

Free Risperdal Lawsuit Evaluation – Call Nationwide 1-800-883-9858

 Risperdal and Breast Development in Young Boys

In November of 2008, the Wall Street Journal posted an online health blog titled “Risperdal Can Have Troubling Side Effects in Boys.” In this blog, the WSJ raised a number of concerns regarding the Johnson & Johnson antipsychotic Risperdal and its potential side effects on young boys, whose bodies have not yet fully developed. Breast enlargement in males, or gynecomastia, is a serious threat to the emotional and psychological health of young boys who are prescribed Risperdal. Gynecomastia in young boys from Risperdal has also been the subject of an increasing number of lawsuit claims filed against Johnson & Johnson in the last couple of years. Last year, the first Risperdal Gynecomastia lawsuit reached a settlement.

Effects of Gynecomastia in Young Boys From Risperdal

A segment on CBS News featured the parents of young boys who experienced gynecomastia from Risperdal. The mother of one young man said that when her son began to develop breast tissue, he asked her if he was a girl. Not satisfied with the answer from his mother, he tried to wear bras be that belonged to his sister. Eventually his breasts grew so large that he required a double mastectomy in order to have them removed. Unfortunately, this surgical treatment for gynecomastia is not covered by many insurance companies because it is considered “cosmetic.”

What in Risperdal Causes Gynecomastia in Young Boys?

Some people attribute Risperdal male breast enlargement to a simple gain in weight, but with some boy’s breasts growing as large as 38D there must be another explanation. The answer lies in the effects of Risperdal on a hormone called prolactin. Taking Risperdal results in much higher prolactin levels than normal, and this hyperprolactinaemia causes breast growth and in some cases even lactation. There has been a lawsuit filed by the parents of a 4 year old boy who grew one breast and experience galactorrhea (flow of breast milk unassociated with childbirth or nursing). Alarmingly, Risperdal is not approved for any use in a child as young as four.

Speak to an Gynecomastia Attorney:  Free Risperdal Lawsuit Consultation

Young boys should never have to undergo the experience of growing female breasts. The experience of gynecomastia can be emotionally damaging for many years to follow. If you or a loved one experienced gynecomastia in young boys from Risperdal, call the Willis Law Firm today. Currently, our firm is reviewing Risperdal male breast growth lawsuits nationwide and is ready to help you and your family fight back against this drug and its harmful side effects.

Risperdal and Male Breast Development

Taking Risperdal, the Johnson & Johnson brand of risperidone, has demonstrated an increased risk of gynecomastia (male breast growth), especially in younger males. Alarmingly, many victims of Risperdal Gynecomastia were prescribed the medication before 2007, the first year in which it was FDA approved for use in children and adolescents.

Lawsuits against the healthcare company have been filed related to Risperdal and Gynecomastia, and the first reached a settlement for an undisclosed amount in the fall of 2012. Last year Bloomberg News stated that there over 100 pending Risperdal lawsuits. However, today that number is in the thousands.

Risperdal Atypical Antipsychotic

Risperidone, manufactured and marketed by Johnson & Johnson as Risperdal, is a psychiatric drug used in the treatment of bipolar I disorder manic episodes, aggression and irritability due to autistic disorder, and schizophrenia. In addition to these FDA approved indications, Johnson & Johnson has also been charged with promoting Risperdal for a number of other medical conditions that are not approved by the Food and Drug Administration. Among these are: anxiety, dementia related psychosis, ADD, and even anger management.

Gynecomastia Caused by Risperdal?

Taking Risperdal can result in a variety of different side effects, but one that has demonstrated long lasting emotional and psychological troubles for young male patients is gynecomastia. Gynecomastia is the medical diagnosis given when a male experiences a growth in breast tissue. Sometimes, a Risperdal Gynecomastia victim will even begin to lactate.

Lawsuit claims filed regarding this male breast enlargement have been filed by the families of boys as young as four years old that have grown female breasts and experienced lactation after taking Risperdal. Gynecomastia results from abnormally high levels of the hormone prolactin, a condition known as hyperprolactinaemia. Many of the boys and young men who experience these horrifying Risperdal side effects were prescribed the drug before it was ever approved for ANY use in children.

Talk to a Risperdal and Gynecomastia Lawyer

Gynecomastia can result from taking Risperdal for both FDA and non-FDA approved uses. If you or a loved one has faced the challenge of gynecomastia or another serious side effect following treatment with Risperdal, call the talented team of product liability attorneys at the Willis Law Firm today. We can provide you with a complimentary case evaluation in order to determine whether you have a potential Risperdal lawsuit. Contact us today; all clients represented on a contingency fee basis.

Free Risperdal Lawsuit Evaluation – Call Nationwide 1-800-883-9858

Breast Enlargement from Risperdal

The Johnson & Johnson atypical antipsychotic medication, Risperdal (generic: risperidone) has been linked to an increased risk of breast enlargement in boys. In the J&J research a growing number of lawsuit claims regarding this irreversible Risperdal gynecomastia side effect have been filed against the company, the first of which was settled in September 2012. The monetary sum received by the Risperdal breast enlargement victim was not made public, but a representative for the boy claimed that he was pleased with the amount.

In April of 2012 Johnson & Johnson was fined $1.2 billion by a judge in Arkansas when a jury decided that the company had understated multiple risks associated with Risperdal, resulting in almost 240,000 violations of the state’s Medicaid laws regarding fraud. Among these risks, was Risperdal Breast Enlargement in Boys. Johnson & Johnson paid out around $180 million to 36 states regarding additional claims that the company was promoting Risperdal and another drug for off-label uses.

Currently Risperdal is only approved for the following indications:
• Schizophrenia in adults and adolescents ages 13-17 years old
• Short term treatment of manic episode in Bipolar I disorder, adults and children/adolescents aged 10-17 years old
• Irritability associated with autistic disorder in children and adolescents ages 5-16 years old

Unfortunately, Johnson & Johnson has been promoting this potentially dangerous drug for a number of other conditions including anger management, anxiety, and even dementia. The FDA released a safety warning in response to the dementia prescription when it was discovered that it increased a risk of cerebrovascular events, including stroke. Additionally, it should be noted that Risperdal is not approved for treatment of dementia-related psychosis by the FDA.

Risperdal Breast Enlargement in Boys in the News

A story on CBS news detailed the stories of several Risperdal gynecomastia victims, and the devastating effects the drug had on their lives. One 19 year old male was prescribed Risperdal beginning at age 7 for ADD. Interestingly this happened before Risperdal was approved for ANY use in children. Also, ADD has never been one of the Risperdal FDA approved uses. Following this prescription, the child became aggressive, sleepy, and developed bowel problems. When this patient was 14, he began to develop women’s breasts. After experiencing Risperdal breast enlargement, this boy asked his mother if he was a girl. His mother says that despite the surgical removal of the breasts and the passage of several years, her son still believes he is a female because of Risperdal gynecomastia.

File a Risperdal Lawsuit: Speak to a Lawyer about Breast Enlargement in Boys

The serious risk of male breast growth is not clearly stated on the packaging for Risperdal (generic: risperidone), and is instead buried in the precautions section of the label in unclear medical terminology. If you or a loved one has experienced gynecomastia or another serious side effect following the use of Risperdal, contact the Willis Law Firm today for a confidential case evaluation. We are currently accepting risperidone clients nationwide; call us today and join the people who are exercising their legal rights in order to hold Johnson & Johnson responsible for their harmful drug.

Free Risperdal Lawsuit Evaluation – Call Nationwide 1-800-883-9858

Risperdal Gynecomastia Lawsuit ? Talk to a Lawyer

The Willis Law Firm is now representing the victims of Risperdal Gynecomastia and other serious side effects in their lawsuit claims against the healthcare company Johnson & Johnson. If you or a loved one has suffered from the growth of male breasts following prescription of the antipsychotic risperidone, you may want to enlist the aid of a Risperdal Gynecomastia Lawyer in seeking monetary damages for the physical, emotional, and financial harm created by this defective drug. In choosing a Risperdal attorney, you will want to make sure to choose a law firm with a proven track record of success in large product liability lawsuit claims. The Willis Law firm is based in Texas and has an influential presence nationwide as well as recognition and respect. With more than 29 years of experience, Mr. Willis is committed to serving the victims of serious personal injuries and would be well suited to be your Risperdal Gynecomastia Lawyer.

Talk to a Risperdal Gynecomastia Lawyer

Mr. Willis specializes in the prosecution of serious personal injury lawsuit claims including injury cases filed against pharmaceutical companies whose products result in serious bodily harm or death. Presently, Mr. Willis and his law firm are evaluating claims against Johnson & Johnson regarding their atypical antipsychotic Risperdal, which can result in Gynecomastia (the development of breasts in men, adolescent males, and young boys). His educational and professional background includes the following: •Baylor University (BA 1978) •South Texas College of Law (JD 1982) •State Bar Of Texas (Admitted to Bar in 1983) •Supreme Court of Texas – Briefing Attorney (1983-1984) •Vice President- Harris County Bar Association (1984-1985) •Board Certified Personal Injury Trial Lawyer (Since 1988) •Association of Trial Lawyers of America (Since 1988) •Texas Bar Foundation (Member since 1996) •State Bar of NY (Admitted to Bar in 2005) •United States Patent Holder

Lawyer Commitment

“My firm is committed to representing individuals and families who have been the victims of a wrongful death or serious personal injury. Although monetary compensation cannot heal the emotional and physical scars left as the result of a serious accident, it can help in many cases to relieve much of the economic stress and hardship associated with the injury or loss of a loved one. Many times it is the only means of support and future security for the injured individual and their family. Litigation may not bring back a loved one, or heal a serious injury, but it may serve to help prevent others from having to endure the same loss.” – David P. Willis

Free Risperdal Gynecomastia Attorney Consultation: File a Risperdal Lawsuit

If you or a loved one have developed breasts or begun to lactate after being prescribed Risperdal, you may be legally entitled to financial compensation. Contact the Willis Law Firm today for a free Risperdal Gynecomastia case evaluation from a Top Texas Trial Attorney. Don’t delay because your time to file may be limited. Call us today.

Tardive Dyskinesia

Risperdal has been linked to increased risks of Tardive Dyskinesia (TD).  Tardive Dyskinesia is a muscular disorder characterized by involuntary movement, particularly in the lower half of the face (tongue, jaw, lips). Examples of these abnormal movements can include:
• Grimacing of the face
• Thrusting of the tongue
• Involuntary movement of the fingers
• Swinging of the jaw
• Repeated chewing motions

The only known cause of this troubling condition is the prolonged use of a number of prescription antipsychotics, including Risperdal. Some Risperdal patients will experience TD sooner than others, and it is unknown how many people this disorder currently afflicts. Currently, the only treatment for tardive dyskinesia is to cease use of the medication, but this remedy only works if the Risperdal tardive dyskenisia is discovered quickly.

Risperdal and Tardive Dyskinesia

Risperidone, also known by its trade name Risperdal is a prescription atypical antipsychotic medication manufactured in marketed by pharmaceutical giant Johnson & Johnson.

This drug is approved for the treatment of the following conditions: • Schizophrenia (in adults and adolescents aged 13-17) • Mania/Mixed Episodes of Bipolar I (in adults and children/adolescents aged 10-17 years) • Irritability Associated with Autistic Disorder (in children/adolescents aged 5-16).

However, J&J has been the subject of lawsuits that claim the company has promoted the sale and use of Risperdal for non FDA-approved uses including: anxiety, dementia related psychosis, and anger management. In 2012, Johnson & Johnson paid $180 million in an attempt to settle these claims.

Does Johnson & Johnson Risperdal Cause Tardive Dyskinesia?

Tardive Dyskinesia (also known as TD) is a well publicized side effect of many antipsychotic drugs, including Risperdal (risperidone). Risperdal Tardive Dyskinesia occurs as the body’s response to the chronic long-term blockage of dopamine (D2) receptors, which increases the number of dopamine receptors in the region of the brain controlling muscle coordination. This drug has also been linked to Parkinson-like symptoms and other muscle disorders for the same reason.

File a Risperdal Tardive Dyskinesia Lawsuit: Free Attorney Consultation

If you or a loved one has experienced tardive dyskinesia or other serious complications following use of the atypical antipsychotic Risperdal, contact the Willis Law firm today for a free Risperdal case consultation. Our firm specializes in the claims of innocent people who are the victims of defective and dangerous drugs like Risperdal.  All of our clients are represented on a contingency fee basis. Call us today to find out how we can help you and your family obtain a settlement for the emotional, physical, and financial damage caused by Risperdal.

Free Risperdal Lawsuit Evaluation – Call Nationwide 1-800-883-9858

Risperdal and Gynecomastia Class Action Lawsuit

In the last year, Johnson & Johnson has lost several class action lawsuits regarding the marketing of its antipsychotic medication Risperdal. The drug is manufactured and marketed by Janssen Pharmaceuticals (a subsidiary of parent company Johnson & Johnson) and is currently approved for the treatment of bipolar disorder (manic episodes), schizophrenia, and irritability associated with autistic disorder in children and adolescents. The drug was approved by the US Food and Drug Administration (FDA) in 1993, but was not approved for use in children until 2006. Risperdal has been the subject of multiple lawsuits regarding its increased risk of gynecomastia, or male breast development. A number of Risperdal Class Action lawsuits have been filed, including one that settled for $1.1 billion by the state of Arkansas.

Risperdal and Gynecomastia Lawsuit

In September of 2012, the first Risperdal gynecomastia lawsuit action was settled on the first day of trial. The 21-year old plaintiff received an undisclosed amount of money in response to his claims that taking Risperdal resulted in his abnormal development of breast tissue, or gynecomastia. The young man was treated with Risperdal from ages 9 to 14, at which point the drug was not yet approved for use in children or adolescents. Other Risperdal class action lawsuits have been filed by the states of Louisiana, South Carolina, and Texas. These class action lawsuits have resulted in hundreds of millions of dollars in fines, as well as action by the United States Department of Justice.

Risperdal Side Effects

Gynecomastia, or the enlargement of breast tissues in males, is only one on a troubling list of Risperdal side effects and adverse events. There are many additional Risperdal side effects that can be very serious and potentially life-threatening, including (but not limited to) the following:
• Suicide
• Risk of death in elderly patients
• Tardive Dyskinesia
• Masking of signs/symptoms of brain tumors, Reye’s syndrome, intestinal obstruction
• Neuroleptic Malignant Syndrome
• Diabetes
• Adverse effect on production of white blood cells
• Dizziness, fainting, lightheadedness
• Prolonged/painful erection

File a Risperdal Class Action Lawsuit

Have you or a loved one suffered from gynecomastia after taking the atypical class of antipsychotic Risperdal? If so, you may be legally entitled to financial compensation. Contact the Willis Law Firm today for a free and confidential evaluation of your potential claim; the lawyers in our office can help you assess your legal options and help you determine whether a lawsuit claim is your best option. Call us today; your time to file may be subject to a statute of limitations.

Free Risperdal Lawsuit Evaluation – Call Nationwide 1-800-883-9858